Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

NCT05701007 · clinicaltrials.gov ↗

COMPLETED

Status

1083

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Metastatic Castration Resistant Prostate Cancer (mCRPC)

Interventions

DRUG: abiraterone
DRUG: enzalutamide
DRUG: docetaxel
DRUG: apalutamide
DRUG: cabazitaxel
DRUG: Radium-223
DRUG: Lutetium-177
DRUG: degarelix
DRUG: goserelin
DRUG: leuprorelin
DRUG: triptorelin

Sponsor

Pfizer